Related Articles
INDUCTION CHEMOTHERAPY IN PRIMARY RESECTABLE HEAD AND NECK TUMORS - A PROSPECTIVE RANDOMIZED TRIAL
Clinical and immunological evaluation of schizophyllan (SPG) in combination with standard chemotherapy in patients with head and neck squamous cell carcinoma
Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study.
Single agent vinorelbine in the treatment of unresectable lung metastases from colorectal cancer
The relationship between allelic imbalance on 17p, p53 mutation and p53 overexpression in head and neck cancer